These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6226764)

  • 1. Nuclear membrane indentations in Huntington's chorea.
    Roos RA; Bots GT
    J Neurol Sci; 1983 Sep; 61(1):37-47. PubMed ID: 6226764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological changes of the nucleus accumbens in Huntington's chorea.
    Bots GT; Bruyn GW
    Acta Neuropathol; 1981; 55(1):21-2. PubMed ID: 6215820
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative analysis of morphological features in Huntington's disease.
    Roos RA; Bots GT; Hermans J
    Acta Neurol Scand; 1986 Feb; 73(2):131-5. PubMed ID: 2939683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nuclear membrane indentation and astrocyte/neuron ratio in Huntington's disease. A quantitative electron microscopic study.
    Roos RA; Bots GT; Hermans J
    J Hirnforsch; 1985; 26(6):689-93. PubMed ID: 2936799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.
    Hirano M; Iritani S; Fujishiro H; Torii Y; Habuchi C; Sekiguchi H; Yoshida M; Ozaki N
    Neuropathology; 2019 Oct; 39(5):331-341. PubMed ID: 31264738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain.
    Curtis MA; Waldvogel HJ; Synek B; Faull RL
    J Chem Neuroanat; 2005 Jul; 30(1):55-66. PubMed ID: 16108100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric analysis of the prefrontal cortex in Huntington's disease.
    Sotrel A; Paskevich PA; Kiely DK; Bird ED; Williams RS; Myers RH
    Neurology; 1991 Jul; 41(7):1117-23. PubMed ID: 1829794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain.
    Curtis MA; Penney EB; Pearson J; Dragunow M; Connor B; Faull RL
    Neuroscience; 2005; 132(3):777-88. PubMed ID: 15837138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.
    Myers RH; Vonsattel JP; Paskevich PA; Kiely DK; Stevens TJ; Cupples LA; Richardson EP; Bird ED
    J Neuropathol Exp Neurol; 1991 Nov; 50(6):729-42. PubMed ID: 1836225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal distribution in the putamen in Huntington's disease.
    Roos RA; Pruyt JF; de Vries J; Bots GT
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):422-5. PubMed ID: 3158722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Huntington's chorea with unilateral ectopic gray matter.
    Nauta HJ; Platts ME
    Can J Neurol Sci; 1981 May; 8(2):181-4. PubMed ID: 6457681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
    Ma L; Nicholson LF
    Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on brain biopsies of patients with Huntington's chorea.
    Tellez-Nagel I; Johnson AB; Terry RD
    J Neuropathol Exp Neurol; 1974 Apr; 33(2):308-32. PubMed ID: 4150800
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.
    Mann JJ; Kaplan RD; Bird ED
    J Neural Transm; 1986; 65(3-4):277-83. PubMed ID: 2940336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of Huntington's chorea. Studies of the ventrobasal complex of the thalamus.
    Dom R; Malfroid M; Baro F
    Neurology; 1976 Jan; 26(1):64-8. PubMed ID: 128708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases.
    Butterworth J; Yates CM; Reynolds GP
    J Neurol Sci; 1985 Feb; 67(2):161-71. PubMed ID: 2858515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective sparing of a class of striatal neurons in Huntington's disease.
    Ferrante RJ; Kowall NW; Beal MF; Richardson EP; Bird ED; Martin JB
    Science; 1985 Nov; 230(4725):561-3. PubMed ID: 2931802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.